NCT00003604View on ClinicalTrials.gov

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery

PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 1997

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

Trial Locations (3)

37901

Baptist Regional Cancer Center - Knoxville, Knoxville

47403

Cancer Care Center for Southern Indiana, Bloomington

68124

Bergan Mercy Medical Center, Omaha

Sponsors
All Listed Sponsors
lead

Cancer Biotherapy Research Group

OTHER

NCT00003604 - Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery | Biotech Hunter | Biotech Hunter